BioSciencs Foro

1
BioSciencs Foro
Joaquin Guinea Chairman of BIOMADRID (www.biomadri
d.org)

November 8th, New York
2
GLOBAL DATA ON THE REGION OF MADRID RD

• 288,800 people employed in the high technology
  sectors (10.7 of the working population).
• Investment in RD 2,400 million euros (1.76 of
  the GDP).
• 40,000 workers in RD.
• 15 universities and more than 50 academic
  research centres.
• 230,000 university students and 2,000 doctorate
  students every year.
• 27.3 of Spanish scientists are in Madrid and
  they produce 31 of the scientific publications
  in Spain.
• More than 20 technology transfer centres.
• Three fully operating scientific parks and
  another three under construction.

3
MADRID BIOSCIENCE REGION IN FIGURES

• 37 companies fully dedicated to biotechnology are
  located in Madrid (32 of the total spanish
  companies). 83 of the investment in RD by
  biotechnology companies in Spain takes place in
  Madrid.
• 400 biomedical companies (with around 25,000
  workers) are located in Madrid.
• 5,000 Life Sciences researchers work in academic
  centres in Madrid.
• 31 of the Spanish biomedical scientific
  publications have its origin in Madrid.
• More than 300 new PhD graduates in Life Sciences
  every year.
• More than 25,000 patients involved in more than
  1,000 clinical trials every year, in 75 hospital
  centres.

4
(No Transcript)
5
SOME EXAMPLES OF MADRID BIOTECH COMPANIES RD
PROJECTS

• Cell Therapy based on the use of stem cells
  obtained from adults.
• Generation of new therapeutic molecules based on
  antibodies for treatment of degenerative and
  inflammatory infectious diseases.
• Development of genetic engineering tools for
  medical diagnosis, the agro-food industry and
  environmental control (clinical and molecular
  diagnosis).
• Development of precision analytical equipment by
  means of biosensors (nanobiotechnology).
• New systems to produce recombinant proteins in
  genetically modified plants (with application in
  chemicalfood industry) or from insect larvae
  (with application in animal health).
• Diagnosis and treatment of allergies by
  development of an individualized molecular
  immunotherapy.

6
BIOTECH SECTOR SUPPORT FROM PUBLIC SECTOR

• EUROPEAN COMMISION
• SPANISH GOVERNMENT
• Ministery of Education
• Ministery of Industry
• MADRID REGIONAL GOVERNMENT
• Directorate General of Technological Innovation
• Madrid Development Agency (IMADE)
• PROMOMADRID
• MADRID CITY COUNCIL